VGHCX Mutual Fund

NAV$203.63
Showing 10 of 109 holdings(as of Mar 31, 2026)Top 10 Weight: 40.77%
#TickerNameWeightSharesMkt ValueShare ChgSectorIndustry
1LLYEli Lilly & Co9.16%3,658,891$3.37B••••••••••••••••••••••
2MRKMerck & Company Inc5.83%17,789,747$2.14B••••••••••••••••••••••
3AZN:LNAstraZeneca PLC5.27%9,897,175$1.94B••••••••••••••••••••••
4JNJJohnson & Johnson3.46%5,203,442$1.27B••••••••••••••••••••••
5GSK:LNGSK plc3.40%45,301,487$1.25B••••••••••••••••••••••
6EWEdwards Lifesciences Corp3.23%14,827,809$1.19B••••••••••••••••••••••
7UNHUnitedhealth Group Incorporated2.91%3,947,604$1.07B••••••••••••••••••••••
8ISRGIntuitive Surg2.54%2,025,229$933.61M••••••••••••••••••••••
9DHRDanaher Corp.2.50%4,836,473$917.00M••••••••••••••••••••••
10BSXBoston Scientific Corp2.47%14,461,266$907.44M••••••••••••••••••••••
Want to see all 109 holdings?View All HoldingsPRO

Top Holdings Themes

PharmaceuticalsBiotechnologyLife Sciences ToolsSemiconductorsAging PopulationMedical DevicesCardiologyHealth & WellnessHealth InsuranceManaged CareDigital HealthRobotics & AutomationFood Innovation

VGHCX Mutual Fund Top Holdings

VGHCX holdings top 10 positions. The top 10 holdings account for 40.8% of the fund, led by Eli Lilly & Co at 9.2%, Merck & Company Inc at 5.8%, AstraZeneca PLC at 5.3%.

VGHCX portfolio concentration is moderate, with the top 10 representing 40.8% of total assets. The largest sector exposure is Health Care at 74.8%.

VGHCX sector allocation provides a detailed breakdown. VGHCX overlap tool shows how holdings compare to other funds in your portfolio.